Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...
Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.
GSK (GSK) has agreed to sell 500K doses of its avian flu vaccine to Canada to protect the country's at-risk individuals and ...
International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...